Publications

All our publications

*Listed are the articles found in the PubMed database.

Publications by “Isabel Lastres Becker”

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition).

Klionsky, DJ, [ .., ], Bartolome, A , [ .., ], Cuadrado, A , [ .., ], Escalante, R , [ .., ], García-Sanz, P , [ .., ], Lastres-Becker, I , [ .., ], León, Y , [ .., ], Martin-Sanz, P , [ .., ], Pajares, M , [ .., ], Rojo, AI , [ .., ], Valverde, AM , [ .., ], Varela-Nieto, I , [ .., ], Villalobo, A , [ .., ], Vincent, O , [ .., ], Tong, CK.

Mammalian ataxin-2 modulates translation control at the pre-initiation complex via PI3K/mTOR and is induced by starvation.

Lastres-Becker, I , Nonis, D, Eich, F, Klinkenberg, M, Gorospe, M, Kötter, P, Klein, FA, Kedersha, N, Auburger, G.

Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rate.

Fittschen, M, Lastres-Becker, I , Halbach, MV, Damrath, E, Gispert, S, Azizov, M, Walter, M, Müller, S, Auburger, G.

Nrf2 protects the lung against inflammation induced by titanium dioxide nanoparticles: A positive regulator role of Nrf2 on cytokine release.

Delgado-Buenrostro, NL, Medina-Reyes, EI, Lastres-Becker, I , Freyre-Fonseca, V, Ji, Z, Hernández-Pando, R, Marquina, B, Pedraza-Chaverri, J, Espada, S , Cuadrado, A , Chirino, YI.

A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice.

Kurz, A, Double, KL, Lastres-Becker, I , Tozzi, A, Tantucci, M, Bockhart, V, Bonin, M, García-Arencibia, M, Nuber, S, Schlaudraff, F, Liss, B, Fernández-Ruiz, J, Gerlach, M, Wüllner, U, Lüddens, H, Calabresi, P, Auburger, G, Gispert, S.

Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice.

Lastres-Becker, I , Brodesser, S, Lütjohann, D, Azizov, M, Buchmann, J, Hintermann, E, Sandhoff, K, Schürmann, A, Nowock, J, Auburger, G.

An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatments.

Lastres-Becker, I , Fernández-Ruiz, J.

Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo.

Lastres-Becker, I , Bizat, N, Boyer, F, Hantraye, P, Fernández-Ruiz, J, Brouillet, E.

The endocannabinoid system and Huntington's disease.

Lastres-Becker, I , De Miguel, R, Fernández-Ruiz, JJ.

Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease.

Lastres-Becker, I , de Miguel, R, De Petrocellis, L, Makriyannis, A, Di Marzo, V, Fernández-Ruiz, J.

The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

Romero, J, Lastres-Becker, I , de Miguel, R, Berrendero, F, Ramos, JA, Fernández-Ruiz, J.

Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.

Lastres-Becker, I , Hansen, HH, Berrendero, F, De Miguel, R, Pérez-Rosado, A, Manzanares, J, Ramos, JA, Fernández-Ruiz, J.

Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease.

Lastres-Becker, I , Berrendero, F, Lucas, JJ, Martín-Aparicio, E, Yamamoto, A, Ramos, JA, Fernández-Ruiz, JJ.

Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors.

López-Rodríguez, ML, Viso, A, Ortega-Gutiérrez, S, Lastres-Becker, I , González, S, Fernández-Ruiz, J, Ramos, JA.

Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets.

Lastres-Becker, I , Cebeira, M, de Ceballos, ML, Zeng, BY, Jenner, P, Ramos, JA, Fernández-Ruiz, JJ.

Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration.

Hansen, HH, Schmid, PC, Bittigau, P, Lastres-Becker, I , Berrendero, F, Manzanares, J, Ikonomidou, C, Schmid, HH, Fernández-Ruiz, JJ, Hansen, HS.

Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease.

Lastres-Becker, I , Fezza, F, Cebeira, M, Bisogno, T, Ramos, JA, Milone, A, Fernández-Ruiz, J, Di Marzo, V.

Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.

Di Marzo, V, Lastres-Becker, I , Bisogno, T, De Petrocellis, L, Milone, A, Davis, JB, Fernandez-Ruiz, JJ.

Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide.

González, S, Romero, J, de Miguel, R, Lastres-Becker, I , Villanua, MA, Makriyannis, A, Ramos, JA, Fernández-Ruiz, JJ.

2'(3')-O-[N- [2- [3- [5-fluoresceinyl] thioureido] ethyl] carbamoyl] adenosine 5'-triphosphate and its Cr(H2O)4 and Co(NH3)4 complex derivatives are new fluorescent tools for labelling ATP binding sites of Na+/K+-ATPase.

Linnertz, H, Lastres Becker, I , Krumscheid, R, Amler, E, Thoenges, D, Schoner, W.